Yahoo
NasdaqGM - Nasdaq Real Time Price USD

Palvella Therapeutics, Inc. (PVLA)

146.15 -5.43 (-3.58%)
At close: October 30 at 4:00:00 PM EDT
148.00 +1.85 (+1.27%)
After hours: October 30 at 7:03:05 PM EDT
Trade PVLA on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
0
0
0
0
Operating Expense
57,741
38,602
14,095
11,869
18,040
Operating Income
-57,741
-38,602
-14,095
-11,869
-18,040
Net Non Operating Interest Income Expense
-3,410
-3,228
-3,675
6,265
-10,364
Other Income Expense
-545
115
336
24,295
-174
Pretax Income
-61,696
-41,715
-17,434
18,691
-28,578
Tax Provision
0
0
0
0
-1,026
Net Income Common Stockholders
-61,696
-41,715
-17,434
17,915
-27,552
Diluted NI Available to Com Stockholders
-61,696
-41,715
-17,434
17,915
-27,552
Basic EPS
-4.85
-3.71
-7.83
1.60
-2.46
Diluted EPS
-4.85
-3.71
-7.83
1.60
-2.46
Basic Average Shares
12,596.71
11,251.25
2,225.93
11,221.31
11,221.31
Diluted Average Shares
12,596.71
11,251.25
2,225.93
11,221.31
11,221.31
Total Operating Income as Reported
-57,741
-38,602
-14,095
-11,869
-18,040
Total Expenses
57,741
38,602
14,095
11,869
18,040
Net Income from Continuing & Discontinued Operation
-61,696
-41,715
-17,434
18,691
-27,552
Normalized Income
-61,249
-41,103
-14,823
-4,892
-27,262.77
Interest Income
4,186
2,590
642
6,265
--
Interest Expense
7,596
5,818
4,317
0
--
Net Interest Income
-3,410
-3,228
-3,675
6,265
-10,364
EBIT
-54,100
-35,897
-13,117
18,691
-18,040
EBITDA
-54,100
-35,897
-13,117
18,691
-18,040
Net Income from Continuing Operation Net Minority Interest
-61,696
-41,715
-17,434
18,691
-27,552
Total Unusual Items Excluding Goodwill
-447
-612
-2,611
23,583
-300
Total Unusual Items
-447
-612
-2,611
23,583
-300
Normalized EBITDA
-53,653
-35,285
-10,506
-4,892
-17,740
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
-10.77
12/31/2022 - 1/2/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: